EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly  Report of China  Biopharmaceuticals  Holdings,
Inc. (the "Company") on Form 10-Q for the quarter ending March 31, 2009 as filed
with the Securities and Exchange  Commission on the date hereof (the  "Report"),
each of the  undersigned,  in the capacities  and on the date  indicated  below,
hereby  certifies,  pursuant to 18 U.S.C.  Section 1350, as adopted  pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1) The report fully complies with the  requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

2) The  information  contained in the Report  fairly  presents,  in all material
respects, the financial condition and results of operations of the Company.

                           /s/ Zhang Jian
                           -----------------------------------------
                           Zhang Jian
                           Chairwoman and Chief Financial Officer
                           May 15, 2009